Florida Senate - 2009 SENATOR AMENDMENT
Bill No. CS/HB 1471, 2nd Eng.
Barcode 140970
LEGISLATIVE ACTION
Senate . House
.
.
.
Floor: 2/WD/3R .
04/30/2009 03:06 PM .
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
Senator Lawson moved the following:
1 Senate Amendment (with title amendment)
2
3 Delete lines 296 - 322
4 and insert:
5 Section 5. Purchasing and repackaging of pharmaceuticals;
6 studies and reports.—
7 (1) The Office of Program Policy Analysis and Government
8 Accountability shall evaluate and submit a report to the
9 Legislature by October 31, 2009, containing recommendations for
10 the statewide consolidation of pharmaceutical repackaging
11 services, including an evaluation of the value to the state of
12 all potential credits, rebates, and cost avoidances that may be
13 realized through repackaging for the Department of Corrections,
14 the Department of Juvenile Justice, the Agency for Persons with
15 Disabilities, the Department of Children and Family Services,
16 and the Department of Health. The Office of Program Policy
17 Analysis and Government Accountability shall also include in its
18 report an analysis of verifiable annual utilization rates for
19 the dispensing of pharmaceuticals for fiscal years 2004-2005
20 through 2008-2009 by each of the five agencies that would
21 participate in a consolidated repackaging services program and
22 the approximate daily output capabilities that would be required
23 to meet the projected average daily utilization rate, as
24 adjusted for future growth projections over the next 3 years for
25 the five agencies. The report shall include an assessment of the
26 projected capitalized cost of leases and equipment and the fully
27 burdened labor rate, projected FTE requirements, and associated
28 operating costs needed by the Department of Health to meet the
29 projected daily utilization requirements for statewide
30 consolidated repackaging services and, if applicable, any cost
31 avoidances or credits that would apply or not apply, as well as
32 any federal regulatory requirements, including any inspection
33 and certification requirements by the United States Food and
34 Drug Administration.
35 (2) The Office of Program Policy Analysis and Government
36 Accountability shall evaluate and submit a report to the
37 Legislature by October 31, 2009, containing recommendations
38 concerning options for implementing a statewide consolidated
39 program for purchasing pharmaceuticals under an adopted
40 formulary to be used by the Department of Corrections, the
41 Department of Juvenile Justice, the Agency for Persons with
42 Disabilities, the Department of Children and Family Services,
43 and the Department of Health and the feasibility of the state
44 obtaining discounts below both wholesale acquisition cost and
45 the Minnesota Multistate Contracting Alliance for Pharmacy
46 prices for the pharmaceuticals listed on the adopted formulary,
47 including the availability and regulatory prerequisites for
48 obtaining 340b pricing under the federal Medicare program.
49 (3) The Department of Health shall study the feasibility of
50 consolidating drug repackaging services through the Department
51 of Health’s central pharmacy and compare that with the costs and
52 benefits of contracting out for such services to a private
53 pharmaceutical repackager licensed by the United States Food and
54 Drug Administration, with preference given to vendors with
55 Florida-based manufacturing operations that will promote the
56 creation and maintenance of jobs in the state. The department
57 shall be prohibited from contracting with any other agency to
58 provide pharmaceutical repackaging services until the results of
59 the Office of Program Policy Analysis and Government
60 Accountability study are reported to the Legislature and the
61 department has submitted a plan for consolidating pharmaceutical
62 repackaging services for the Department of Corrections, the
63 Department of Juvenile Justice, the Agency for Persons with
64 Disabilities, the Department of Children and Family Services,
65 and the Department of Health, consistent with the
66 recommendations of the Office of Program Policy Analysis and
67 Government Accountability and the Pharmacy and Therapeutic
68 Advisory Council. The plan shall be submitted to the Legislature
69 by January 31, 2010.
70
71 ================= T I T L E A M E N D M E N T ================
72 And the title is amended as follows:
73 Delete lines 24 - 29
74 and insert:
75 requiring the Office of Program Policy Analysis and Government
76 Accountability to evaluate and submit reports to the Legislature
77 regarding consolidation of pharmaceutical repackaging services
78 and implementation of a statewide consolidated pharmaceutical
79 purchasing program; requiring the Department of Health to
80 conduct a study; prohibiting the department from entering into
81 certain contracts until the results of the Office of Program
82 Policy Analysis and Government Accountability report are
83 submitted to the Legislature and the department has submitted a
84 plan to the Legislature for consolidation of pharmaceutical
85 repackaging services; transferring, renumbering, and amending s.